Heyholder
‹ Activism Filings

Xcell Therapeutics Inc. Q3 consolidated revenue KRW 1.1 billion, operating loss KRW 3.0 billion

Xcell Therapeutics Inc.· Preliminary Earnings

AI summary · Not investment advice

Q3 2026 consolidated revenue was KRW 1,064 million, up 217.9% year over year and down 45.1% from the prior quarter, with an operating loss of KRW 2,982 million.

Operating profit · current quarter

KRW -3.0 billion

Key facts

Revenue (current quarter)
KRW 1.1 billion
Net income (current quarter)
KRW -3.1 billion
Operating profit change vs. prior-year quarter
-25.6%
Revenue change vs. prior-year quarter
217.9%
Net income change vs. prior-year quarter
-32.3%
Period
Jul 1, 2026 – Sep 30, 2026
Basis
Consolidated
Revenue (previous quarter)
KRW 1.9 billion
Revenue (prior-year quarter)
KRW 335.0 million
Revenue change vs. previous quarter
-45.1%
Operating profit (previous quarter)
KRW -2.8 billion
Operating profit (prior-year quarter)
KRW -2.4 billion
Operating profit change vs. previous quarter
-8.3%
Net income (previous quarter)
KRW -2.8 billion
Net income (prior-year quarter)
KRW -2.3 billion
Net income change vs. previous quarter
-10.7%
Revenue (year to date)
KRW 4.0 billion
Operating profit (year to date)
KRW -8.7 billion
Net income (year to date)
KRW -8.7 billion
Net income attributable to owners (current quarter)
KRW -3.1 billion

Commentary

AI commentary · Not investment advice

What happened

Excel Therapeutics gave a preliminary look at its consolidated third-quarter results. Revenue for the quarter was KRW 1.064 billion. Operating profit, which is profit from the core business, was KRW -2.982 billion. Net income, the final profit after all items, was KRW -3.057 billion. These are preliminary figures and may differ from the final results.

In the company's terms

Revenue fell 45.1% from the previous quarter (KRW 1.937 billion). It rose 217.9% from the same quarter a year earlier (KRW 335 million).

What changes for shareholders

Operating profit was KRW -2.754 billion in the previous quarter and KRW -2.375 billion a year earlier. The change was -8.3% from the previous quarter and -25.6% from a year earlier. Net income was KRW -2.762 billion in the previous quarter and KRW -2.310 billion a year earlier. The change was -10.7% from the previous quarter and -32.3% from a year earlier.

For the first three quarters combined, revenue was KRW 4.022 billion. Operating profit was KRW -8.651 billion and net income was KRW -8.747 billion. Net income attributable to owners of the parent company was KRW -3.057 billion for the quarter.

Comments

No comments yet

Comments from shareholders will appear here.